Immunomodulatory treatment of early onset multiple sclerosis: Results of an Italian Co-operative Study

A. Ghezzi, M. Trojano, I. L. Simone, A. Bellacosa, S. Stecchi, C. Scandellari, G. Marrosu, G. Spinicci, F. Patti, A. Cristaldi, M. P. Amato, E. Portaccio, V. Pilato, M. Zaffaroni, A. Bellantonio, R. Fantozzi, L. Moiola, V. Martinelle, G. Comi, N. MilaniC. Milanese, E. Scarpini, R. Clerici, E. Merelli, A. Guerra, P. Gallo, P. Perini, R. Bergamaschi, P. Veggiotti, C. Pozzilli, E. Onesti, A. Bertolotto, M. Capobianco, S. Malucchi

Research output: Contribution to journalArticle

Abstract

The ITEM study group was organised in Italy to evaluate the effectiveness and safety of interferon-beta (IFNβ) and glatiramer acetate (GA) in multiple sclerosis (MS) patients treated before 16 years of age. Eighty-six patients (58 females) were included in our database: as subjects with pre- and treatment duration

Original languageEnglish
JournalNeurological Sciences
Volume26
Issue numberSUPPL. 4
DOIs
Publication statusPublished - Dec 2005

    Fingerprint

Keywords

  • Adolescence
  • Childhood
  • Glatiramer acetate
  • Interferon-beta
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Ghezzi, A., Trojano, M., Simone, I. L., Bellacosa, A., Stecchi, S., Scandellari, C., Marrosu, G., Spinicci, G., Patti, F., Cristaldi, A., Amato, M. P., Portaccio, E., Pilato, V., Zaffaroni, M., Bellantonio, A., Fantozzi, R., Moiola, L., Martinelle, V., Comi, G., ... Malucchi, S. (2005). Immunomodulatory treatment of early onset multiple sclerosis: Results of an Italian Co-operative Study. Neurological Sciences, 26(SUPPL. 4). https://doi.org/10.1007/s10072-005-0512-8